Navigation Links
Envera Appoints Michael McErlean Fermentation Manager
Date:5/22/2013

West Chester, PA (PRWEB) May 22, 2013

Envera announced today that Michael McErlean has joined the company as Fermentation Manager. Mr. McErlean has an extensive background in cell production and served in a variety of leadership positions throughout his career.

Mike Matheny, President and Owner of Envera stated, “We are very pleased to have Mike join our team”. “Mike’s background is perfectly suited to oversee our newly installed large scale fermentation and downstream processing equipment”, added Matheny. “Mike’s hands on experience optimizing production protocols, establishing preventative maintenance procedures, and troubleshooting equipment is exactly what we need for this stage of Envera’s growth”, concluded Matheny.

Mr. McErlean holds a Bachelor’s Degree from Millersville University. Mike’s professional career includes 18 years of experience divided between Centocor, Merck Sharp & Dohme, and Fibrocell Science. During his time with these companies Mike gained hands on experience running a variety of bioreactors and downstream equipment as well as the implementation of new procedures and processes. Michael was also responsible for the generation of SOP’s, departmental logistics, and Quality/Regulatory issues.

“I am pleased to join a technology based company that is making a difference in the world”, stated McErlean. “Envera’s focus on using naturally occurring microorganisms to replace harsh chemicals, remediate environmental waste, and promote the growth and health of plants and animals was particularly appealing to me”, added Mike. “I am eager to utilize the newly installed fermentation and downstream processing equipment to support Envera’s expanding business”, finished McErlean.

Mr. McErlean will be located at Envera’s West Chester, Pennsylvania corporate offices and can be reached at 484-593-4002 or mmcerlean(at)envera(dot)com.

Envera is a bioscience-based company focused on the production of environmentally friendly products. With decades of experience in the isolation, large scale production, stabilization and product formulation of microorganisms, Envera is a leader in the development and commercialization of microbial and enzyme based products for the consumer, institutional, agricultural, waste water, and bioremediation markets. Envera’s technology platform includes expertise in the areas of bacteriology, mycology, enzymology, and chemistry.

Contact: Michael Matheny at mmatheny(at)envera(dot)com or phone 484-593-4002 for more information.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10752565.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Envera Increases Scientific Staff
2. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
3. Elsevier / MEDai Appoints Tom Zajac as New President
4. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
5. Hybrid Fuels, Inc. Appoints Industry Expert as New CEO
6. BioStorage Technologies Appoints New Member to Board of Directors
7. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
8. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
9. PuraMed BioScience, Inc. Appoints Sue A. Baacke, CPA, as CFO
10. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
11. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... March 22, 2017 MarketNewsUpdates.com News Commentary  ... The ... are being pressured as of late due to the rise ... management has a dramatic impact on patient,s quality of life ... activities for identifying new forms of opioid formulations that prevent ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced Tallahassee, ... their live events series, “Stem Cell Therapy: The Next Phase in the Evolution of ... Stem Cell Research and Therapy Act, Okyanos maintains a mission to help ...
(Date:3/22/2017)... ... March 21, 2017 , ... ... innovative Quantum peristaltic pump with patented ReNu single-use (SU) cartridge technology. Engineered ... for high-pressure feed pumps in SU tangential flow filtration (TFF), virus filtration ...
(Date:3/22/2017)... BALTIMORE , March 22, 2017  Personal ... of its cancer testing contract with the U.S. ... earlier tumor profiling assay with the company,s new ... a comprehensive, clinically actionable pan-cancer profiling test that ... to assess potential patient response to checkpoint inhibitor ...
Breaking Biology Technology:
(Date:2/28/2017)... News solutions for biometrics, bag drop and New ADA-compliant ... At PTE ... March, Materna will present its complete end-to-end passenger journey, ... real benefit for passengers. To accelerate the whole passenger handling ... solutions to take passengers through the complete integrated process with ...
(Date:2/26/2017)... -- Securus Technologies, a leading provider of civil and ... corrections and monitoring, announces the appointment of a ... often, too many offenders return to jail or ... to tackle this ongoing problem and improve the ... significant steps are underway, Securus continues to invest ...
(Date:2/21/2017)... ARMONK, N.Y. and PORTLAND, Ore. ... IBM ) and the Avamere Family of Companies (Avamere ... Care) today announced a six-month research study that will ... caregivers improve eldercare at senior living and health centers. ... facilities, Avamere hopes to gain insights into physical and ...
Breaking Biology News(10 mins):